Adriana Carr

1.3k total citations
29 papers, 1.1k citations indexed

About

Adriana Carr is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Adriana Carr has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 17 papers in Immunology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Adriana Carr's work include Glycosylation and Glycoproteins Research (22 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Immunotherapy and Immune Responses (9 papers). Adriana Carr is often cited by papers focused on Glycosylation and Glycoproteins Research (22 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Immunotherapy and Immune Responses (9 papers). Adriana Carr collaborates with scholars based in Cuba, Argentina and Spain. Adriana Carr's co-authors include Luis E. Fernández, O. Valiente, Rolando Pérez, Enrique Rengifo, Circe Mesa, Kazuo Kon, Shinji Ando, Hatsue Waki, Gloria Marquina and Ana María Vázquez and has published in prestigious journals such as Journal of Clinical Oncology, Vaccine and Molecular Cancer Therapeutics.

In The Last Decade

Adriana Carr

29 papers receiving 1.0k citations

Peers

Adriana Carr
P O Livingston United States
Helen Chung United States
Dick J. Schol Netherlands
A C Morgan United States
Ingmarie Höidén‐Guthenberg Sweden
J Taylor-Papadimitriou United Kingdom
Lori Westendorf United States
Lorenzo Tarli Switzerland
Ilenia Pellicciotta United States
P O Livingston United States
Adriana Carr
Citations per year, relative to Adriana Carr Adriana Carr (= 1×) peers P O Livingston

Countries citing papers authored by Adriana Carr

Since Specialization
Citations

This map shows the geographic impact of Adriana Carr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adriana Carr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adriana Carr more than expected).

Fields of papers citing papers by Adriana Carr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adriana Carr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adriana Carr. The network helps show where Adriana Carr may publish in the future.

Co-authorship network of co-authors of Adriana Carr

This figure shows the co-authorship network connecting the top 25 collaborators of Adriana Carr. A scholar is included among the top collaborators of Adriana Carr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adriana Carr. Adriana Carr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hernández, Ivones, Idania Rodeiro, Ken Declerck, et al.. (2021). Marine Seagrass Extract of Thalassia testudinum Suppresses Colorectal Tumor Growth, Motility and Angiogenesis by Autophagic Stress and Immunogenic Cell Death Pathways. Marine Drugs. 19(2). 52–52. 18 indexed citations
2.
Osorio, Marta, et al.. (2019). Aberrant expression of N-glycolyl GM3 ganglioside is associated with the aggressive biological behavior of human sarcomas. BMC Cancer. 19(1). 556–556. 6 indexed citations
3.
Blanco, Rancés, et al.. (2017). Double Expression of Epidermal Growth Factor Receptor and N-Glycolyl GM3 Ganglioside in Human Malignant Tumors: A Study in Four Different Clinical Scenarios. 2017(1). 1–6. 1 indexed citations
4.
Blanco, Rancés, et al.. (2015). Prognostic Significance of N-Glycolyl GM3 Ganglioside Expression in Non-Small Cell Lung Carcinoma Patients: New Evidences. Pathology Research International. 2015. 1–12. 29 indexed citations
5.
Osorio, Marta, et al.. (2013). NGcGM3/VSSP vaccine as treatment for melanoma patients. Human Vaccines & Immunotherapeutics. 9(6). 1237–1240. 17 indexed citations
6.
Zhong, Yi, Yunteng Wu, Cong Li, et al.. (2012). N‐Glycolyl GM3 ganglioside immunoexpression in oral mucosal melanomas of Chinese. Oral Diseases. 18(8). 741–747. 14 indexed citations
7.
Blanco, Rancés, et al.. (2012). Immunoreactivity of the 14F7 Mab (Raised against N-Glycolyl GM3 Ganglioside) as a Positive Prognostic Factor in Non-Small-Cell Lung Cancer. Pathology Research International. 2012. 1–12. 32 indexed citations
8.
Mulens‐Arias, Vladimir, Ana de la Torre, Patricia Marinello, et al.. (2010). Immunogenicity and safety of a NeuGcGM3 based cancer vaccine: Results from a controlled study in metastatic breast cancer patients.. Human Vaccines. 6(9). 736–744. 36 indexed citations
9.
10.
Osorio, Marta, Elías Gracia, Giselle Saurez, et al.. (2008). Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: Results of a phase Ib/IIa study. Cancer Biology & Therapy. 7(4). 488–495. 35 indexed citations
11.
Chakrabandhu, Krittalak, et al.. (2008). Anti-ganglioside antibody-induced tumor cell death by loss of membrane integrity. Molecular Cancer Therapeutics. 7(7). 2033–2041. 56 indexed citations
12.
Saurez, Giselle, et al.. (2004). 265 First clinical evidences of antigen spreading in metastatic melanoma patients treated with a NGcGM3/VSSP/Montanide ISA 51 vaccine: a phase I/IIb study. European Journal of Cancer Supplements. 2(8). 81–82. 1 indexed citations
13.
Carr, Adriana, Rolando Camacho, Marta Osorio, et al.. (2003). Immunotherapy of Advanced Breast Cancer With a Heterophilic Ganglioside (NeuGcGM3) Cancer Vaccine. Journal of Clinical Oncology. 21(6). 1015–1021. 82 indexed citations
14.
Carr, Adriana, et al.. (2002). In Vivo and In Vitro Anti-Tumor Effect of 14F7 Monoclonal Antibody. PubMed. 21(6). 463–468. 33 indexed citations
15.
Carr, Adriana, Zaima Mazorra, Daniel F. Alonso, et al.. (2001). A purified GM3 ganglioside conjugated vaccine induces specific, adjuvant-dependent and non-transient antitumour activity against B16 mouse melanoma in vitro and in vivo. Melanoma Research. 11(3). 219–227. 28 indexed citations
16.
Carr, Adriana, Zaima Mazorra, Ana María Vázquez, et al.. (2000). A Mouse IgG 1 Monoclonal Antibody Specific for N -Glycolyl GM3 Ganglioside Recognized Breast and Melanoma Tumors. Hybridoma. 19(3). 241–247. 105 indexed citations
17.
18.
Marquina, Gloria, Hatsue Waki, Kazuo Kon, et al.. (1996). Gangliosides expressed in human breast cancer.. PubMed. 56(22). 5165–71. 221 indexed citations
19.
Cabrera‐Rode, Eduardo, et al.. (1995). Glycolipids as the Major Autoantigens of Cytoplasmatic Islet Cell Antibodies. Autoimmunity. 20(3). 145–151. 10 indexed citations
20.
Vázquez, Ana María, Mauro Alfonso, Boel Lanne, et al.. (1995). Generation of a Murine Monoclonal Antibody Specific for N -Glycolylneuraminic Acid-Containing Gangliosides That Also Recognizes Sulfated Glycolipids. Hybridoma. 14(6). 551–556. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P O Livingston Breakdown of academic impact, for papers by Helen Chung Breakdown of academic impact, for papers by Dick J. Schol Breakdown of academic impact, for papers by A C Morgan Breakdown of academic impact, for papers by Ingmarie Höidén‐Guthenberg Breakdown of academic impact, for papers by J Taylor-Papadimitriou Breakdown of academic impact, for papers by Lori Westendorf Breakdown of academic impact, for papers by Lorenzo Tarli Breakdown of academic impact, for papers by Ilenia Pellicciotta
Rankless by CCL
2026